TargetMol
Roflumilast is an orally available, long-acting inhibitor of phosphodiesterase (PDE) type 4 (PDE4), with anti-inflammatory and potential antineoplastic activities. Upon administration, roflumilast and its active metabolite roflumilast N-oxide selectively and competitively bind to and inhibit PDE4, which leads to an increase of both intracellular levels of cyclic-3′, 5′-adenosine monophosphate (cAMP) and cAMP-mediated signaling.
More Information
Supplier Page
TargetMol
Roflumilast is an orally available, long-acting inhibitor of phosphodiesterase (PDE) type 4 (PDE4), with anti-inflammatory and potential antineoplastic activities. Upon administration, roflumilast and its active metabolite roflumilast N-oxide selectively and competitively bind to and inhibit PDE4, which leads to an increase of both intracellular levels of cyclic-3′, 5′-adenosine monophosphate (cAMP) and cAMP-mediated signaling.
More Information
Supplier Page
TargetMol
Azilsartan is an Angiotensin 2 Receptor Blocker. The mechanism of action of azilsartan is as an Angiotensin 2 Type 1 Receptor Antagonist. The physiologic effect of azilsartan is by means of Decreased Blood Pressure.
More Information
Supplier Page
TargetMol
Azilsartan is an Angiotensin 2 Receptor Blocker. The mechanism of action of azilsartan is as an Angiotensin 2 Type 1 Receptor Antagonist. The physiologic effect of azilsartan is by means of Decreased Blood Pressure.
More Information
Supplier Page
Repaglinide
200 mg
| Purity Not Available
TargetMol
Repaglinide is a benzoic acid derivative that stimulates insulin secretion from the pancreas and is used in the therapy of type 2 diabetes. Repaglinide has been linked to rare instances of clinically apparent acute liver injury.
More Information
Supplier Page
Repaglinide
50 mg
| Purity Not Available
TargetMol
Repaglinide is a benzoic acid derivative that stimulates insulin secretion from the pancreas and is used in the therapy of type 2 diabetes. Repaglinide has been linked to rare instances of clinically apparent acute liver injury.
More Information
Supplier Page
TargetMol
Mianserin hydrochloride is a tetracyclic compound with antidepressant effects. it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors. It may cause drowsiness and hematological problems.
More Information
Supplier Page
TargetMol
Mianserin hydrochloride is a tetracyclic compound with antidepressant effects. it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors. It may cause drowsiness and hematological problems.
More Information
Supplier Page
Thioctamide
10 mg
| Purity Not Available
TargetMol
Lipoamide is a trivial name for 6, 8-dithiooctanoic amide. It is 6, 8-dithiooctanoic acid’s functional form where the carboxyl group is attached to protein (or any other amine) by an amide linkage (containing -NH2).
More Information
Supplier Page
Thioctamide
200 mg
| Purity Not Available
TargetMol
Lipoamide is a trivial name for 6, 8-dithiooctanoic amide. It is 6, 8-dithiooctanoic acid’s functional form where the carboxyl group is attached to protein (or any other amine) by an amide linkage (containing -NH2).
More Information
Supplier Page
